Next Article in Journal
Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress
Previous Article in Journal
Anticoagulation in the Elderly
Open AccessArticle

Effects of Moxifloxacin on Human Neutrophil and T-Lymphocyte Functions in Vitro

1
Medical Research Council Unit for Inflammation and Immunity, Faculty of Health Sciences, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South Africa
2
Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(12), 3570-3580; https://doi.org/10.3390/ph3123570
Received: 14 September 2010 / Revised: 29 November 2010 / Accepted: 8 December 2010 / Published: 13 December 2010
Moxifloxacin is useful in the treatment of respiratory infections, including community-acquired pneumonia, and also shows promise in the treatment of tuberculosis, a clinical setting which necessitates extended administration of this agent. Relatively little is known, however, about the effects of this agent on the antimicrobial and proliferative activities of human neutrophils and T-lymphocytes, respectively. In the current study, we have investigated the effects of moxifloxacin at therapeutic concentrations and greater (1–20 µg/mL) on cytosolic Ca2+ fluxes, generation of antimicrobial reactive oxygen species (ROS), and release of the primary granule protease, elastase, following activation of the cells with the chemoattractant, fMLP (1 µM), or the phorbol ester, PMA (25 ng/mL), using radiometric, chemiluminescence, and colourimetric procedures, respectively. The effects of moxifloxacin on mitogen-activated proliferation of T cells and expression of the interleukin-2 (IL-2) receptor (CD25) were measured using radiometric and flow cytometric procedures respectively. With the exception of elastase release, which was significantly increased (P < 0.05) by treatment of the cells with moxifloxacin at 10 and 20 µg/mL, none of the other neutrophil or lymphocyte functions was affected by moxifloxacin. These observations suggest that extended use of this agent is unlikely to compromise the protective functions of neutrophils and T-lymphocytes and may even potentiate neutrophil-mediated antimicrobial activity by increasing the release of elastase. View Full-Text
Keywords: calcium; CD25; elastase; N-formyl-L-methionyl-L-leucyl-L-phenylalanine; interleukin-2; phorbol myristate acetate; mitogen-activated proliferation; reactive oxygen species calcium; CD25; elastase; N-formyl-L-methionyl-L-leucyl-L-phenylalanine; interleukin-2; phorbol myristate acetate; mitogen-activated proliferation; reactive oxygen species
Show Figures

Figure 1

MDPI and ACS Style

Potjo, M.; Cockeran, R.; Theron, A.J.; Feldman, C.; Anderson, R. Effects of Moxifloxacin on Human Neutrophil and T-Lymphocyte Functions in Vitro. Pharmaceuticals 2010, 3, 3570-3580.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop